GPC Biotech - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

GPC Biotech M&A Summary

GPC Biotech has acquired 1 company of its own.

GPC Biotech has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

GPC Biotech Ownership

Who owns GPC Biotech?

GPC Biotech is owned by Agennix AG. It was acquired on November 5, 2009.

GPC Biotech Business Overview

Where is GPC Biotech headquartered?

GPC Biotech is headquartered in Princeton, New Jersey.

What sector is GPC Biotech in?

GPC Biotech is a life science company.

When was GPC Biotech founded?

GPC Biotech was founded in 1992.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1

GPC Biotech Inc.

101 College Road East,
Princeton, New Jersey 08540
United States,
(609) 524-1000

GPC Biotech is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections.

M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
Sell (0.0/yr) # - - - - - - 0

Most Recent M&A

Company Date Value Type
Mitotix Inc. 2000-07-24 - Add-on Acquisition
Princeton, New Jersey
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) - - -
Total 1 - - -

By Geo

State/Country Buy Value Sell Value
United States 1 - - -
  New Jersey 1 - - -
Total 1 - - -

 Subscribe to unlock this and 204,239
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 4.6K Private Equity Firms
  • 196K M&A Transactions
  • 200K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 77K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.